Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia

BACKGROUND: The extent of short-acting Beta-2-agonist (β(2)-agonist) (SABA) use across Asian countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we assessed SABA prescriptions and clinical outcomes in patients with asthma from Asia. METHODS: This cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao-Chien, Djajalaksana, Susanthy, Sharma, Latha, Theerakittikul, Theerakorn, Lim, Hui Fang, Yoo, Kwang Ha, Yu-Lin, Andrea Ban, Diaz, Dina V., Yang, Lala, Beekman, Maarten J.H.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587767/
https://www.ncbi.nlm.nih.gov/pubmed/37869560
http://dx.doi.org/10.1016/j.waojou.2023.100823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587767/
https://www.ncbi.nlm.nih.gov/pubmed/37869560
http://dx.doi.org/10.1016/j.waojou.2023.100823

Ejemplares similares